Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

26.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
26.9K
Stem Cell Culture01:17

Stem Cell Culture

5.9K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

2.0K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simultaneous transformations of view and place coding across reference frames in the macaque brain.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Support Regulation Strategy Synergistic with Ru Single-Atom Catalyst for Energy-Saving Hydrogen Production Assisted by Green Electrosynthesis of Azotetrazolate.

Inorganic chemistry·2025
Same author

2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione protects against MPP<sup>+</sup>-induced neurotoxicity by ameliorating oxidative stress, apoptosis and autophagy in SH-SY5Y cells.

Metabolic brain disease·2025
Same author

Distinct Hippocampal Expression Profiles of lncRNAs in Obese Type 2 Diabetes Mice Exhibiting Cognitive Impairment.

Neuromolecular medicine·2024
Same author

Spatial dissociation between recognition and navigation in the primate hippocampus.

Science advances·2024
Same author

2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione Ameliorates Diabetic Cognitive Impairment Through Inhibiting Hif3α and Apoptosis.

Frontiers in pharmacology·2022

Related Experiment Video

Updated: Dec 15, 2025

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K

Current progress in stem cell therapy for type 1 diabetes mellitus.

Shuai Chen1, Kechen Du1, Chunlin Zou2

  • 1Key Laboratory of Longevity and Ageing-Related Disease of Chinese Ministry of Education, Center for Translational Medicine and School of Preclinical Medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.

Stem Cell Research & Therapy
|July 10, 2020
PubMed
Summary

Type 1 diabetes (T1DM) treatment faces challenges with insulin therapy and transplantation. Stem cell therapy offers potential for generating insulin-producing cells (IPCs) to cure diabetes, but requires further research for clinical use.

Keywords:
Insulin-producing cellsPancreatic isletsStem cellsTransplantationType 1 diabetes mellitus

More Related Videos

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.1K
Author Spotlight: Advancements and Challenges in &#946;-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.4K

Related Experiment Videos

Last Updated: Dec 15, 2025

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.1K
Author Spotlight: Advancements and Challenges in &#946;-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.4K

Area of Science:

  • Endocrinology and Metabolic Diseases
  • Regenerative Medicine
  • Immunology

Background:

  • Type 1 diabetes mellitus (T1DM) is an autoimmune disease causing pancreatic beta cell loss and insulin deficiency.
  • Current treatments like insulin injections and transplantation have limitations, including donor shortages and procedural complexities.
  • Stem cell therapy presents a promising avenue for T1DM treatment by potentially restoring insulin production.

Purpose of the Study:

  • To review current advancements in generating insulin-producing cells (IPCs) from various precursor cells.
  • To discuss the progress and challenges of stem cell-based therapies for diabetes.
  • To highlight areas requiring further investigation for clinical feasibility.

Main Methods:

  • Review of existing scientific literature on stem cell differentiation and transplantation for T1DM.
  • Analysis of strategies for deriving insulin-producing cells (IPCs) from different stem cell sources.
  • Evaluation of the current state of stem cell-based therapeutic approaches for diabetes.

Main Results:

  • Significant progress has been made in deriving insulin-producing cells (IPCs) from various stem cell types.
  • Stem cell-based therapies have shown promise in preclinical models of diabetes.
  • Several challenges remain, including cell survival, immune rejection, and functional integration in vivo.

Conclusions:

  • Stem cell therapy holds considerable potential for a functional cure for Type 1 diabetes mellitus.
  • Further research is essential to overcome existing hurdles and translate these findings into safe and effective clinical treatments.
  • Developing robust protocols for generating and transplanting functional insulin-producing cells (IPCs) is critical.